Drug Repurposing for Rare Diseases: A Role for Academia

Background: The European Commission highlights in its Pharmaceutical Strategy the role of academic researchers in drug repurposing, especially in the development of orphan medicinal products (OMPs). This study summarizes the contribution of academia over the last 5 years to registered repurposed OMP...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Berg, Sibren, de Visser, Saco, Leufkens, Hubert G.M., Hollak, Carla E.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564285/
https://www.ncbi.nlm.nih.gov/pubmed/34744726
http://dx.doi.org/10.3389/fphar.2021.746987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564285/
https://www.ncbi.nlm.nih.gov/pubmed/34744726
http://dx.doi.org/10.3389/fphar.2021.746987

Ejemplares similares